Madrigal Pharmaceuticals ... (MDGL)
NASDAQ: MDGL
· Real-Time Price · USD
364.08
-7.29 (-1.96%)
At close: Aug 15, 2025, 11:36 AM
Madrigal Pharmaceuticals Fail-to-Deliver
Total FTD Shares
6.05K
Below Average
FTD / Avg. Volume
1.69%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jun 27, 2025,
Madrigal Pharmaceuticals Inc. has
6,051
shares failed to deliver, representing 1.69%
of the average daily volume of
357,606
shares. Over the past year, the monthly average FTD is
4,150
shares, with the current level 46% above
the historical average, indicating
moderate
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jun 27, 2025 | 300.75 | 6.05K | +13972.09% |
| May 28, 2025 | 270.87 | 43 | -83.40% |
| Apr 30, 2025 | 333.91 | 259 | -93.82% |
| Mar 31, 2025 | 331.23 | 4.19K | -89.98% |
| Feb 28, 2025 | 341.27 | 41.81K | +464500.00% |
| Jan 30, 2025 | 338.29 | 9 | -99.59% |
| Dec 30, 2024 | 311.62 | 2.21K | +6.46% |
| Nov 29, 2024 | 328.19 | 2.07K | +2780.56% |
| Oct 30, 2024 | 215.93 | 72 | -87.69% |
| Sep 24, 2024 | 223.07 | 585 | -77.92% |
| Aug 30, 2024 | 247.13 | 2.65K | +2576.77% |
| Jul 30, 2024 | 279.99 | 99 | +11.24% |
| Jun 28, 2024 | 280.16 | 89 | -99.31% |
| May 31, 2024 | 236.16 | 12.9K | +554.31% |
| Apr 29, 2024 | 201.07 | 1.97K | +333.41% |
| Mar 27, 2024 | 258.81 | 455 | -94.81% |
| Feb 27, 2024 | 239.8 | 8.77K | +1742.65% |
| Jan 29, 2024 | 226.99 | 476 | +257.89% |
| Dec 27, 2023 | 236.75 | 133 | +33.00% |
| Nov 21, 2023 | 188.44 | 100 | +376.19% |
| Oct 27, 2023 | 120.4 | 21 | -99.22% |
| Sep 29, 2023 | 146.04 | 2.68K | +962.30% |
| Aug 04, 2023 | 194.48 | 252 | +66.89% |
| Jul 25, 2023 | 210.63 | 151 | -82.09% |
| Jun 27, 2023 | 203.88 | 843 | +1656.25% |
| May 26, 2023 | 284.88 | 48 | -58.26% |
| Apr 28, 2023 | 312 | 115 | -27.22% |
| Mar 31, 2023 | 242.26 | 158 | +7800.00% |
| Feb 28, 2023 | 271.01 | 2 | -83.33% |
| Jan 24, 2023 | 306 | 12 | n/a |